Registry of diagnostics and treatment outcomes in patients with cardiogenic shock in Poland

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This registry aims to gather comprehensive data on the epidemiology, diagnostics, treatment, and outcomes of patients experiencing cardiogenic shock in Poland. It will involve participation from various cardiology departments equipped with 24-hour hemodynamic laboratories, collecting data through electronic case report forms. The study will focus on understanding the current state of treatment, including the use of mechanical circulatory support, to identify areas for improvement in patient care. Data will be collected over a six-month period, followed by a six-month observation phase to track patient outcomes.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Cardiogenic shock patients of all etiologies in SCAI stage B, C, D, E.
* age \> 18 years old
* persistent hemodynamic failure defined as systolic blood pressure of \<90 mmHg for ≥ 30 minutes or the requirement for inotropic or vasopressor agents with evidence of hypoperfusion of the peripheral organs

Exclusion Criteria:

* patients without return of spontaneous circulation who were considered to extracorporeal cardiopulmonary resuscitation (ECPR)
* primary septic, anaphylactic, hypovolemic shock
* post-operative cardiogenic shock
* end-stage of heart failure disqualified from mechanical circulatory support and heart transplantation

Where it's running

• Wroclaw Medical University
  Wroclaw, Poland Recruiting
• Institute of Heart Diseases, Wroclaw Medical University, Wroclaw, Poland
  Wroclaw, Lower Silesian Voivodeship, Poland Not yet recruiting

Study contacts

• Study coordinator: Wiktor Kuliczkowski, MD,PhD
• Email: wiktor.kuliczkowski@umw.edu.pl
• Phone: +48 71 736 42 51

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Factors Influencing Outcomes in ECMO and Impella Patients

  This study tests whether metabolic and thyroid hormone changes help predict survival for adults on ECMO or Impella at a single Hungarian cardiac ICU.

  Recruiting Gottsegen National Cardiovascular Institute · Budapest · NCT07885618

• Evaluating a noninvasive tissue sensor to detect cardiogenic shock earlier in heart patients

  This pilot, noninvasive study tests whether the NIRSense wearable can help detect deterioration in adults with cardiogenic shock risk due to heart attack or heart failure.

  Recruiting NIRSense Inc. · Weston, Florida · NCT07825363

• Safety and Efficacy of an Extracorporeal Ventricular Assist System for Cardiogenic Shock

  This study tests whether an extracorporeal ventricular assist device can safely provide short-term heart support and help patients with cardiogenic shock or trouble weaning from bypass.

  Recruiting China National Center for Cardiovascular Diseases · Beijing, Beijing Municipality · NCT07769528

• Left Ventricular Support and Advanced Monitoring in AMI–Cardiogenic Shock: Immediate Impella Use and PAC/Monitoring vs Standard Care

  In adults with heart attack-related cardiogenic shock, this trial tests whether using an Impella left ventricular assist device and/or protocolized pulmonary artery catheter monitoring improves survival compared with standard care.

  Recruiting Leipzig Heart Science gGmbH · Leipzig, Saxony · NCT07762560

• CRP Apheresis for infarct-related cardiogenic shock

  This study tests whether selectively removing C-reactive protein with apheresis, in addition to standard care, helps people with cardiogenic shock after a heart attack.

  Recruiting Leipzig Heart Science gGmbH · Leipzig, Saxony · NCT07687017

• Compare two ventilator modes in adults with cardiac ICU needs and invasive ventilation

  This pilot tests whether volume-controlled versus pressure-controlled ventilation can be safely used in adults with heart disease and respiratory failure who need invasive ventilation.

  Recruiting Mayo Clinic · Rochester, Minnesota · NCT07656259

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.